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Strengths and limitations of this study
 ► The study identifies overweight and nulliparous 
mothers with obesity who are at risk for maternal 
and neonatal complications using specific body 
mass index (BMI) cut-offs applicable for a multieth-
nic diverse population.
 ► The study compares the risks across Arab and 
non-Arab maternal ethnic groups.
 ► The study uses multiple imputation techniques to 
handle missing BMI data.
 ► The study used nationality as a surrogate for ethnic-
ity, which was valid in this sample given the dichot-
omous nature of the grouping used.
 ► The study did not consider potential confounders 
such as socioeconomic status since such data were 
not available in the dataset.
AbStrACt
background Given the small number of studies on the 
topic, we aimed to identify the impact of prepregnancy 
maternal body mass index (BMI) on adverse pregnancy 
outcomes (POs) in a low-risk, multiethnic population, and 
to calculate related population attributable fractions (PAFs).
Methods This retrospective cohort study included 1134 
nulliparous women of 50 nationalities (classified into 
Arab and non-Arab ethnicity) in Qatar who had their first 
antenatal visit at a Primary Healthcare Corporation (PHCC) 
facility in June 2016–March 2017 and their PO at a Hamad 
Medical Corporation facility before 10 November 2017. 
We used multiple imputation to handle missing values and 
multivariate logistic regression to calculate adjusted ORs 
(aORs) for adverse POs in overweight and women with 
obesity.
results Overweight Arab women and women with obesity 
were at high risk for gestational diabetes mellitus (GDM) 
(aOR=2.38, 95% CI 1.51 to 3.84) and caesarean section 
(aOR=1.57, 95% CI 1.00 to 2.48). Non-Arab women with 
obesity were at high risk for pre-eclampsia (aOR=3.83, 
95% CI 1.00 to 15.00). PAFs showed that 41.63% of pre-
eclampsia, 17.36% of pregnancy-induced hypertension, 
17.17% of large for gestational age, 15.89% of preterm 
deliveries, 14.75% of GDM and 13.99% of caesarean 
sections could be avoided if all mothers had normal 
prepregnancy BMI. There were no major differences in 
PAFs by ethnicity.
Conclusion Adverse POs were attributable to maternal 
obesity. This suggests that, in contrast to existing PHCC 
protocol, overweight and women with obesity in Qatar 
should be targeted earlier in their pregnancy; preferably 
prior to getting pregnant. We observed ethnic differences 
in the risk of adverse POs.
bACkground
More than half of women of childbearing 
age in the high-income countries are either 
overweight or obese,1 and the percentage 
of women who are obese at their first ante-
natal visit nearly doubled between 1990 and 
2004.2 Maternal obesity has been associated 
with infertility and can cause spontaneous 
pregnancy loss in early gestation.3 Gesta-
tional diabetes,4 pre-eclampsia,5 gestational 
hypertension, depression, instrumental 
vaginal delivery, caesarean section delivery6 
and surgical site infection have been associ-
ated with maternal obesity.7 Maternal obesity 
can also impact neonatal outcomes, such 
as preterm birth, large-for-gestational-age 
babies, fetal defects, congenital anomalies 
and perinatal death. Length of hospital stay 
was also reported as an adverse outcome of 
maternal obesity.7
Most published studies on the effect of 
obesity on pregnancy outcomes have focused 
on primarily homogenous regional popu-
lations that are not ethnically diverse,8 but 
some researchers have shown that ethnic 
differences can have an impact on the asso-
ciation between obesity and adverse preg-
nancy outcomes.9 This impact is particularly 
relevant for countries like Qatar, which has 
a diverse, multiethnic, transient popula-
tion. The 2012 WHO STEPwise approach to 
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Surveillance survey for Qatar showed that 68.3% of adult 
females were overweight and 43.2% were obese,10 high-
lighting the significance of the maternal obesity problem 
in the country. The public healthcare system in Qatar is 
broken down into primary and secondary/tertiary care 
systems, with primary care administered by the Primary 
Healthcare Corporation (PHCC), and secondary/tertiary 
care administered by the Hamad Medical Corporation 
(HMC). Both systems classify pregnancies as high risk 
when the mother is obese class III or higher (body mass 
index (BMI)≥40 kg/m2), has a pre-existing medical condi-
tion and/or obstetric complications, as per the guidelines 
of the Ministry of Health. Women with high-risk pregnan-
cies are directly referred to dedicated antenatal clinics of 
the HMC for specialised management. However, women 
with a BMI <40 kg/m2, but who are still overweight or 
obese, are cared for through the PHCC; they are referred 
to the HMC only if they develop complications or for 
delivery.
Population attributable fractions (PAFs) are used to 
identify the burden of risk factors for a disease or condi-
tion in a given population.11 Few studies have looked at 
PAFs of maternal obesity.12 Obesity is highly prevalent in 
Qatar, hence it is critical to study PAFs associated with 
obesity in different ethnic groups to quantify the burden 
of disease that can be attributed to obesity, and thereby 
help develop targeted management strategies. We aimed 
to identify the impact of prepregnancy maternal BMI on 
adverse pregnancy outcomes in a low-risk, multiethnic 
population, and to calculate related PAFs.
MethodS
The PHCC Database is linked to the Birth Register of 
Qatar; it includes information on all PHCC visits, and 
thus includes prepregnancy and maternal characteris-
tics (eg, age, nationality, pre-existing conditions), and 
pregnancy and neonatal outcomes. For this retrospective 
cohort study, we used the PHCC Database to identify all 
nulliparous women with singleton pregnancies who had 
their first antenatal visit at a PHCC facility between 1 June 
2016 and 1 March 2017 and their pregnancy outcome at 
a HMC facility before 10 November 2017 (n=1245). The 
follow-up care for the mother and child initially happens 
at HMC and may then refer back to PHCC, however, 
this follow-up care was outside the scope of our study. 
We wanted to target women with low-risk pregnancies as 
defined by the Ministry of Health of Qatar. Therefore, 
we excluded women with high-risk pregnancies, that is, 
those with a pregnancy outcome prior to 24 weeks of 
gestation (n=8), those who were obese class II and higher 
(BMI≥35 kg/m2, n=80) or who were under the age of 18 
at their first antenatal visit (n=23). Women who gave birth 
to babies with indeterminate sex (n=2), or who experi-
enced stillbirth (n=3), fetal death (n=4) or neonatal 
death (n=1) were also excluded. Among the exclusions 
were 10 women who met more than one exclusion 
criterion; therefore, the final study sample consisted of 
1134 women.
Patient and public involvement
This study involved secondary analysis of data collected 
by PHCC during its routine interactions with the patients. 
No additional patient or public contact was undertaken 
in this study.
Maternal ethnicity
Included women were of 50 unique nationalities, and 
maternal ethnicity was categorised as Arab or non-Arab 
based on nationality. Women were designated as Arab 
if they were citizens of one of the 22 countries included 
in the list of League of Arab States (LAS).13 Our Arab 
study women came from 18 of these countries (Algeria, 
Bahrain, Egypt, Iraq, Jordan, Kuwait, Lebanon, Libya, 
Morocco, Oman, Palestine, Qatar, Saudi Arabia, Sudan, 
Syria, Tunis, United Arab Emirates and Yemen). The LAS 
have a common language (Arabic) and share a number 
of cultural, social and dietary habits which may put them 
at different lifestyle and obesity-related risks as compared 
with non-Arabs. Women of other nationalities were desig-
nated as non-Arabs.
Prepregnancy body mass index
Prepregnancy BMI was calculated based on information 
recorded at the most recent prepregnancy visit available 
in the PHCC Database. If this primary care visit was prior 
to 12 weeks from the date of the first antenatal visit, the 
BMI was treated as missing. Prepregnancy BMI was cate-
gorised as normal weight (BMI<25 kg/m2), overweight 
(BMI 25–29.99 kg/m2) and obese (BMI≥30 kg/m2) 
based on standard WHO guidelines.14 However, different 
BMI cut-offs were applied to Asians (n=405, overweight: 
BMI 23–27.5 kg/m2; obese: BMI≥27.5 kg/m2), as recom-
mended by the WHO expert consultation.15 Sensitivity 
analyses, the results of which are not presented in this 
manuscript, showed that our application of different BMI 
cut-offs for Asians was valid, as using standard cut-offs 
underestimated the risk in that population.
Adverse pregnancy outcomes, adverse neonatal outcomes 
and risk factors
Investigated adverse pregnancy outcomes included GDM, 
pregnancy-induced hypertension (PIH), pre-eclampsia, 
preterm delivery, assisted vaginal delivery and caesarean 
section. Investigated adverse neonatal outcomes included 
macrosomia, large for gestational age, small for gesta-
tional age, neonatal intensive care unit referrals and 
Apgar score <7 at 1 min. Risk factors considered included 
maternal age, maternal ethnicity and pre-existing condi-
tions such as diabetes mellitus type 1 or 2, hypertension 
and thyroid conditions. Retrospective review of patient 
medical records including doctors’ notes were used 
to identify pre-existing conditions and most adverse 
outcomes such as GDM. Diagnosis of macrosomia, large 
for gestational age and small for gestational age was based 
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on the weight percentiles calculator available from the 
WHO website.16 17
Statistical analysis
Maternal characteristics and risk factors were tabulated 
using the observed data, and differences in the demo-
graphics across BMI categories were compared using 
Pearson’s χ2 test. Thereafter, as prepregnancy BMI was 
not available for 101 (8.9%) of the study subjects, multiple 
imputation was performed to assign these values, with 
the underlying assumption that BMI values were missing 
at random.18 19 Univariate and multivariate associations 
between maternal BMI category and adverse pregnancy 
and neonatal outcomes were assessed by logistic regres-
sion, using the imputed dataset.
Known and potential risk factors such as maternal 
age at first antenatal visit, pre-existing diabetes mellitus 
type 1 or 2, pre-existing hypertension and pre-existing 
thyroid conditions were included as covariates in the final 
model. Maternal ethnicity was assessed as potential risk 
factor while computing adjusted ORs (aORs) for associa-
tions between BMI category and adverse pregnancy and 
neonatal outcomes. Subgroup analysis was conducted by 
computing crude and aORs for adverse pregnancy and 
neonatal pregnancy outcomes separately for Arab and 
non-Arab mothers.
The aORs were used to compute PAFs of overweight 
and obesity for Arab and non-Arab mothers. PAFs were 
used to estimate the proportion of adverse pregnancy 
and neonatal outcomes that could be prevented if either 
one of two scenarios were true20: 1) if overweight and 
women with obesity were all of normal weight before 
pregnancy; 2) if overweight and obese mothers had a 
one-category drop in BMI before pregnancy (ie, obese to 
overweight, and overweight to normal weight). Scenario 
0 was denoted the reference scenario, that is, the current 
population as represented by the data. These scenarios 
were also analysed by ethnicity.
PAFs and corresponding 95% CIs were computed using 
a user-written procedure (punaf) in the Stata software.20 
All analyses in this research report were performed using 
the Stata 1521 software package and Microsoft Excel. The 
significance level for this study was set at 5%, so p value 
≤0.05 was considered to be statistically significant.
reSultS
In our study sample, 86.33% of women were aged 18–30 
years and 59.17% were of Arab ethnicity. The study 
sample included women from 50 countries, representing 
an extremely diverse data set. The most common risk 
factor among women with obesity was pre-existing thyroid 
conditions (5.22%). Term deliveries (gestational age 
37–41 weeks) accounted for 89.77% of births in the study 
sample (table 1a).
GDM was the most common adverse pregnancy 
outcome and was observed in 35.89% of the study sample, 
followed by caesarean section (24.96%). Pre-eclampsia 
was observed in 3.44% of the study sample. The prev-
alence of GDM, caesarean section and pre-eclampsia 
increased with increasing BMI category (table 1b).
Obese Arab mothers had statistically significant, higher 
odds of developing GDM (aOR=2.41, 95% CI 1.51 to 
3.84, p<0.01) when compared with normal-weight Arab 
mothers. Although the odds were higher for obese 
non-Arab mothers when compared with their normal-
weight counterparts (aOR=1.58, 95% CI 0.96 to 2.62, 
p=0.07), these odds were not as high as those observed 
for Arab mothers, and the association was not statistically 
significant. Non-Arab women with obeseity had signifi-
cantly higher odds (aOR=3.83, 95% CI 0.98 to 15.00, 
p=0.05) of developing pre-eclampsia when compared 
with normal-weight non-Arab women. Finally, the 
odds of caesarean section were significant among over-
weight Arab mothers, as compared with their normal-
weight counterparts (aOR=1.57, 95% CI 1.00 to 2.48, 
p=0.05), but this association was not significant among 
obese Arab mothers or among obese non-Arab mothers 
when compared with their normal-weight counterparts 
(table 2). Although higher odds were observed in obese 
(figure 1) and overweight (figure 2) mothers in both 
ethnic groups, p values were not statistically significant 
for most adverse pregnancy or neonatal outcomes when 
compared with normal-weight counterparts.
Population attributable fractions
For pre-eclampsia, a one-category reduction in BMI 
among Arab mothers corresponded to a PAF of 46.28% 
for women with obesity and 38.61% for overweight 
women (figure 3). For PIH, a one-category drop in BMI 
for women with obesity corresponded to a PAF of 50.83%, 
meaning that 50.83% of PIH cases could be avoided if 
obese mothers reduced their BMI category to overweight 
(figure 3). Corresponding PAFs for neonatal outcomes 
were 65.23% for macrosomia and 30.42% for Apgar score 
<7 at 1 min. Some of the CIs and PAFs were negative (eg, 
small for gestational age and assisted vaginal delivery), 
indicating a protective effect of obesity on these outcomes, 
which means that removing obesity could increase these 
risks (tables 3 and 4).
For GDM, a one-category reduction in BMI corre-
sponded to a PAF of 24.72% and 24.58% for obese Arab 
and non-Arab mothers, respectively (figure 3). The PAF 
for macrosomia if all women were of normal weight 
before pregnancy was 13.73% for non-Arab women and 
6.78% for Arab mothers (figure 4). The PAFs for neonatal 
outcomes after a one-category reduction in BMI are not 
shown in the figures 3 and 4, as they are mostly negative 
due to the small number of cases.
diSCuSSion
Our study confirms that there is an association between 
prepregnancy maternal BMI and adverse pregnancy and 
neonatal pregnancy outcomes in multiethnic popula-
tions, using aORs and PAFs. Previous studies have shown 
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Table 1A Selected characteristics of the study sample by prepregnancy maternal body mass index (BMI) in Qatar (n=1134)
 
Prepregnancy BMI category
Normal weight
(n=404)
Overweight 
(n=399)
Obese
(n=230)
Missing
(n=101)
Total
(n=1134) P value
Maternal age 
(years)
  <0.001
  18–24 212 (52.48%) 141 (35.34%) 73 (31.74%) 48 (47.52%) 474 (41.8%)
  25–30 157 (38.86%) 195 (48.87%) 114 (49.57%) 39 (38.61%) 505 (44.53%)
  31–44 35 (8.66%) 63 (15.79%) 43 (18.7%) 14 (13.86%) 155 (13.67%)
Maternal ethnicity           0.005
  Arab 254 (62.87%) 240 (60.15%) 114 (49.57%) 63 (62.38%) 671 (59.17%)   
  Non-Arab 150 (37.13%) 159 (39.85%) 116 (50.43%) 38 (37.62%) 463 (40.83%)   
Pre-existing hypertension
  Yes 8 (1.98%) 10 (2.51%) 4 (1.74%) 2 (1.98%) 24 (2.12%) 0.94
  No 396 (98.02%) 389 (97.49%) 226 (98.26%) 99 (98.02%) 1110 (97.88%)
Pre-existing diabetes mellitus type 1 or 2
  Yes 5 (1.24%) 4 (1%) 4 (1.74%) 0 (0%) 13 (1.15%) 0.67
  No 399 (98.76%) 395 (99%) 226 (98.26%) 101 (100%) 1121 (98.85%)
Pre-existing thyroid condition
  Yes 18 (4.46%) 10 (2.51%) 12 (5.22%) 2 (1.98%) 42 (3.7%) 0.22
  No 386 (95.54%) 389 (97.49%) 218 (94.78%) 99 (98.02%) 1092 (96.3%)
Gestational age at delivery (weeks)
  <37 32 (7.92%) 40 (10.03%) 28 (12.17%) 10 (9.9%) 110 (9.7%) 0.60
  37–41+6 days 370 (91.58%) 357 (89.47%) 200 (86.96%) 91 (90.1%) 1018 (89.77%)
  ≥42 2 (0.5%) 2 (0.5%) 2 (0.87%) 0 (0%) 6 (0.53%)
Values shown as number (%).
χ2 test was used to determine differences across the BMI categories.
Fisher’s exact test was used when cell count was <5.
Bold values are statisticaly significant.
Table 1B Distribution of adverse pregnancy and neonatal outcomes by prepregnancy maternal body mass index (BMI) in 
Qatar (N=1134)
Prepregnancy BMI category
Normal weight
(n=404)
Overweight
(n=399)
Obese
(n=230)
Missing
(n=101)
Total
(n=1134) P value
Pregnancy outcomes
  Gestational diabetes mellitus 118 (29.21%) 140 (35.09%) 108 (46.96%) 41 (40.59%) 407 (35.89%) <0.001
  Pregnancy-induced hypertension 14 (3.47%) 14 (3.51%) 17 (7.39%) 1 (0.99%) 46 (4.06%) 0.038
  Pre-eclampsia 8 (1.98%) 14 (3.51%) 15 (6.52%) 2 (1.98%) 39 (3.44%) 0.013
  Preterm delivery 32 (7.92%) 40 (10.03%) 28 (12.17%) 8 (7.92%) 108 (9.52%) 0.21
  Assisted vaginal delivery 66 (16.34%) 62 (15.54%) 40 (17.39%) 11 (10.89%) 179 (15.78%) 0.831
  Caesarean section 80 (19.8%) 107 (26.82%) 69 (30%) 27 (26.73%) 283 (24.96%) 0.008
Neonatal outcomes
  Macrosomia 11 (2.72%) 8 (2.01%) 13 (5.65%) 1 (0.99%) 33 (2.91%) 0.034
  Large for gestational age 25 (6.19%) 31 (7.77%) 23 (10%) 7 (6.93%) 86 (7.58%) 0.22
  Small for gestational age 65 (16.09%) 55 (13.78%) 32 (13.91%) 22 (21.78%) 174 (15.34%) 0.606
  NICU referral 36 (8.91%) 46 (11.53%) 22 (9.57%) 10 (9.9%) 114 (10.05%) 0.449
  Apgar score <7 at 1 min 19 (4.7%) 17 (4.26%) 14 (6.09%) 4 (3.96%) 54 (4.76%) 0.582
Continued
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Prepregnancy BMI category
Normal weight
(n=404)
Overweight
(n=399)
Obese
(n=230)
Missing
(n=101)
Total
(n=1134) P value
Values shown as number (%).
χ2 test was used to determine differences across the BMI categories.
Bold values are statisticaly significant.
NICU, neonatal intensive care unit.
Table 1B Continued
similar strengths of association between overweight 
and obesity and GDM,22 PIH,22 23 preterm delivery,12 24 
assisted vaginal delivery,22 25 caesarean section,22 25 macro-
somia,12 large for gestational age24 and small for gestation 
age.24 25 However, the present study found much higher 
ORs for pre-eclampsia in non-Arab mothers. This could 
be attributed to the large portion of Asian mothers in the 
non-Arab group, who have been reported to be suscep-
tible to pre-eclampsia.26
Our results confirm those of a recent study on nullip-
arous women in Qatar, which reported a higher inci-
dence of GDM, caesarean section and PIH in women with 
obesity,27 whereas overweight women were reported to 
have higher caesarean section rates only.27 However, the 
overall incidence of these outcomes was much lower than 
in our study sample (GDM: 15% vs 35.89% in our study 
sample; caesarean section: 16% vs 24.98%). These differ-
ence cannot be explained by the data alone, since the 
earlier study27 was carried out in a tertiary care setting, 
whereas this research focused on primary care settings.
The PAFs we report are much higher than those from 
some published studies,12 due to the high prevalence 
of overweight and obesity (ie, exposure) in our study 
sample. Pre-eclampsia stands out, as any reduction in BMI 
category yielded a substantial reduction in the burden of 
this condition. A one-category reduction in BMI showed 
a much higher possibility of disease reduction among 
women with obesity than among overweight women, 
whether they were Arab or non-Arab. However, caesarean 
section was an exception to this trend, and showed a 
lesser PAF for a one-category reduction in BMI among 
women with obesity than overweight women. This can be 
explained by the higher OR for caesarean section in over-
weight women as compared with women with obesity in 
both ethnic groups. It should be noted that a causal rela-
tionship between exposures and outcomes is generally 
assumed in PAF calculations. However, this relationship 
may not necessarily exist, and PAFs should be considered 
accordingly.
Unlike other reports, the exposure variable in our study 
was not self-reported. We used standard WHO recom-
mended BMI cut-offs, except in the Asian population, 
in which Asian-specific cut-offs were applied. Results of a 
sensitivity analysis indicated that the use of these Asian-spe-
cific cut-offs is indeed clinically important in multiethnic 
populations. Indeed, Asian mothers must be classified 
as overweight and obese using the WHO-recommended 
cut-offs for Asians, otherwise high-risk patients may not 
be properly identified during antenatal care.
Patient nationality was used as a surrogate for ethnicity, 
but it is common for people to change their citizen-
ship through immigration, which could have limited 
the strength of the conclusions of this study. However, a 
detailed analysis of nationalities revealed that the number 
of patients claiming citizenship to countries that are most 
likely targets for migrants was minimal (Canadians=0, 
Australians=0, Americans=3, British=1, French=1). There-
fore, the use of nationality as a surrogate for ethnicity is 
reasonable and valid for this dataset.
Other reports from Qatar showed higher rates of 
conditions such as diabetes mellitus and cardiovascular 
diseases, which were not reflected in our study. These 
low rates may represent an information bias which did 
not allow us to properly adjust for potential confounders. 
Data on socioeconomic status and health centre location 
were not available; hence it is not possible to attribute 
missing values to these factors or to any other variables 
for which data were not available.
GDM, pre-eclampsia and caesarean section were signifi-
cantly associated with prepregnancy BMI among our 
overweight and obese mothers, who are not generally 
considered to have at-risk pregnancies by the healthcare 
system in Qatar. High prevalence of GDM in normal-
weight mothers (29.21%) indicates that BMI alone 
cannot explain the problem, which is instead related to 
population norms and characteristics. High risk of pre-ec-
lampsia in overweight and obese mothers, especially 
among non-Arabs, indicates that early screening and 
management of hypertensive disorders is needed for this 
group. This implies that clinical screening is indicated 
for all mothers regardless of their prepregnancy BMI or 
ethnicity, preferably at the start of pregnancy.
The rate of caesarean section was very high in our study 
sample (25%), especially considering that pregnancies in 
overweight and women with obesity are currently consid-
ered low risk by the healthcare system in Qatar. The odds 
of caesarean section were uncharacteristically high and 
similar in overweight and obese mothers regardless of 
ethnicity. Clinical implications cannot be drawn from 
these results without properly separating the caesarean 
sections by their indications (medically necessary vs 
elective), which were not available in the study sample. 
Our findings of an association between prepregnancy 
maternal BMI and caesarean section may not properly 
copyright.
 o
n
 Septem
ber 16, 2019 at Qatar University. Protected by
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-029757 on 8 September 2019. Downloaded from 
6 Shaukat S, Nur U. BMJ Open 2019;9:e029757. doi:10.1136/bmjopen-2019-029757
Open access 
Table 2 ORs and 95% CIs of the association between adverse pregnancy and neonatal pregnancy outcomes and body mass 
index (BMI) category by ethnicity after multiple imputation (n=1134)
Arabs Non-Arabs
Prevalence
Adjusted OR
(95% CI) P value Prevalence
Adjusted OR
(95% CI) P value
Pregnancy outcomes
Gestational diabetes mellitus
  Overweight 92 (34.98%) 1.24 (0.84 to 1.82) 0.28 64 (36.99%) 1.23 (0.76 to 2.00) 0.40
  Obese 66 (51.97%) 2.38 (1.51 to 3.84) <0.01 54 (43.2%) 1.60 (0.97 to 2.65) 0.07
Pregnancy-induced hypertension
  Overweight 11 (4.18%) 1.66 (0.63 to 4.38) 0.31 3 (1.73%) 0.41 (0.11 to 1.61) 0.20
  Obese 4 (3.15%) 1.21 (0.34 to 4.31) 0.76 13 (10.4%) 2.41 (0.93 to 6.327) 0.07
Pre-eclampsia
  Overweight 6 (2.28%) 1.11 (0.33 to 3.71) 0.86 9 (5.2%) 2.56 (0.66 to 9.97) 0.18
  Obese 7 (5.51%) 2.64 (0.81 to 8.65) 0.11 8 (6.4%) 3.83 (0.98 to 15.00) 0.05
Preterm delivery
  Overweight 26 (9.89%) 1.26 (0.66 to 2.41) 0.48 18 (10.4%) 1.22 (0.57 to 2.61) 0.61
  Obese 14 (11.02%) 1.35 (0.63 to 2.91) 0.45 17 (13.6%) 1.69 (0.78 to 3.68) 0.18
Assisted vaginal delivery
  Overweight 38 (14.45%) 0.94 (0.57 to 1.55) 0.82 28 (16.18%) 0.87 (0.48 to 1.58) 0.65
  Obese 20 (15.75%) 1.01 (0.55 to 1.86) 0.97 22 (17.6%) 0.97 (0.52 to 1.81) 0.93
Caesarean section
  Overweight 66 (25.1%) 1.57 (1.00 to 2.48) 0.05 51 (29.48%) 1.05 (0.64 to 1.74) 0.83
  Obese 32 (25.2%) 1.46 (0.83 to 2.53) 0.20 45 (36%) 1.43 (0.84 to 2.44) 0.19
Neonatal outcomes
Macrosomia
  Overweight 7 (2.66%) 0.86 (0.30 to 2.42) 0.77 1 (0.58%) 0.37 (0.04 to 3.39) 0.38
  Obese 6 (4.72%) 1.48 (0.49 to 4.48) 0.49 7 (5.6%) 3.05 (0.77 to 12.06) 0.11
Large for gestational age
  Overweight 19 (7.22%) 1.06 (0.53 to 2.14) 0.87 15 (8.67%) 1.52 (0.61 to 3.79) 0.37
  Obese 13 (10.24%) 1.46 (0.66 to 3.20) 0.35 12 (9.6%) 1.75 (0.70 to 4.41) 0.23
Small for gestational age
  Overweight 34 (12.93%) 0.84 (0.49 to 1.43) 0.52 30 (17.34%) 0.93 (0.52 to 1.67) 0.82
  Obese 17 (13.39%) 0.90 (0.44 to 1.82) 0.77 19 (15.2%) 0.84 (0.44 to 1.60) 0.59
NICU referral
  Overweight 26 (9.89%) 1.15 (0.63 to 2.11) 0.65 23 (13.29%) 1.30 (0.64 to 2.64) 0.46
  Obese 8 (6.3%) 0.64 (0.26 to 1.55) 0.32 17 (13.6%) 1.30 (0.61 to 2.77) 0.49
Apgar score <7 at 1 min
  Overweight 13 (4.94%) 1.24 (0.53 to 2.92) 0.63 6 (3.47%) 0.59 (0.19 to 1.80) 0.47
  Obese 8 (6.3%) 1.72 (0.66 to 4.46) 0.27 6 (4.8%) 0.86 (0.30 to 2.48) 0.50
For each ethnic group, normal weight was considered the reference category (OR=1) for calculating ORs. All outcomes were adjusted for 
maternal age at first antenatal visit. In addition, pre-eclampsia for pre-existing diabetes, and pre-existing hypertension, preterm delivery 
for pre-existing comorbid conditions, assisted vaginal delivery for pre-existing comorbid conditions, caesarean section for pre-existing 
comorbid conditions, macrosomia for pre-existing diabetes, large for gestational age for pre-existing diabetes and small for gestational 
age was adjusted for pre-existing diabetes and pre-existing hypertension.
NICU, neonatal intensive care unit.
represent the true nature of the outcome risk and expo-
sure, and should therefore be interpreted with caution.
As has been mentioned in above paragraphs, the retro-
spective cohort nature of this study limited our ability 
to validate or verify the elements of the dataset and 
other potential confounders through additional patient 
contact. The anonymity of the data by design made it 
impossible to undertake such a follow-up. The strength of 
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Figure 1 Adjusted ORs and 95% CIs for obese nulliparous mothers by ethnicity. GDM, gestational diabetes mellitus; PIH, 
pregnancy-induced hypertension; NICU, neonatal intensive care unit; LGA, large for gestational age; SGA, small for gestational 
age.
our findings is therefore directly related to the strength 
of the dataset used. The number of missing values in the 
exposure variable, the prepregnancy BMI, meant that we 
were unable to ascertain a direct relationship for those 
records. However, the impact of such was minimised by 
using the multiple imputation techniques. The PAFs were 
computed using the punaf user written extension for 
Stata software and manual calculations for such cannot 
be undertaken due to the computational complexity of 
the task.
Adverse pregnancy outcomes were attributable to 
maternal obesity for even low-risk patients. This suggests 
that, in contrast to the existing PHCC protocol which 
focuses only on high-risk pregnancies for intervention, 
overweight and women with obesity in Qatar should also 
be targeted earlier in their pregnancy, preferably prior 
to getting pregnant. We observed ethnic differences in 
the risk of adverse pregnancy outcomes. Planning and 
prevention approaches at the preconception stage are 
needed to raise awareness and reduce the burden of 
these adverse outcomes on the healthcare system. There 
is a need for an ecological approach that addresses soci-
etal, cultural and personal influences by promoting good 
health at all levels. A top-down approach would work best 
to formulate public health policy to combat the issues 
raised. A combination of these public health interven-
tions can help achieve the WHO Non-Communicable 
Disease Targets for the Global Action Plan by 2025.
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Figure 2 Adjusted ORs and 95% CIs for overweight nulliparous mothers by ethnicity. C-section, caesarean section; GDM, 
gestational diabetes mellitus; PIH, pregnancy-induced hypertension; NICU, neonatal intensive care unit; LGA,large for 
gestational age; SGA, small for gestational age.
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Table 4 Population attributable fractions (%) and 95% CIs of adverse pregnancy and neonatal outcomes by prepregnancy 
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